The University Hospital Centre of Brussels (CHU Brussels) was established in 2015. It coordinates care provision and pools a range of support services for the four public university hospitals associated with the IRIS network: CHU Saint-Pierre, CHU Brugmann, the Jules Bordet Institute and the Queen Fabiola Children’s University Hospital (QFCUH). CHU Brussels also works in close liaison with a range of privileged partners such as the the City of Brussels, the Brussels CPAS (Public Centre for Social Welfare) and the VUB/ULB (Free University of Brussels).
These hospital institutions are spread across seven hospital sites, of which six are located on City of Brussels territory, and the seventh in the Schaerbeek district.
These seven locations constitute around 371,761 m² of buildings spread over more than 26 hectares.
With 1,781 authorised beds, CHU Brussels accounts for 21 % of the beds in the 22 hospital institutions in the Brussels-Capital Region..
With 1,781 authorised beds, CHU Brussels accounts for 21 % of the beds in the 22 hospital institutions in the Brussels-Capital Region.
Number of authorised beds in CHU Brussels on 31/12/2016
Beyond its primary role of providing accessible quality care to everybody, CHU Brussels has some other key roles:
Train future healthcare professionals and ensure continuous training of its staff
Care for patients, at every stage of their lives, regardless of their socio-economic or philosophical affiliation
Research, innovate and stimulate diagnostic and therapeutic methodes
Perform roles of general economic benefit by providing care to the most disadvantaged and by working closely with local CPAs
Play an economic and societal role both as a business and as a public employer
Research, a fundamental role of CHU Brussels
Around one in three cases of breast cancer will lead to metastases despite treatment administered during the early stages of the illness. BIG-AURORA is an international research project coordinated by the Jules Bordet Institute, which seeks to understand why breast cancer generates metastases and why certain patients respond very well to standard treatment and others do not. It will enable researchers to discover new treatment targets that are better adapted to men and expectant women suffering from metastatic illnesses.
1Recorded admissions include all days charged as admissions as defined by INAMI (National Sickness and Invalidity Insurance Institute), for both conventional hospitalisation and day patients, all medical disciplines combined.
2The item “Other receipts” covers mainly those arising from previous years, grants and subsidies, re-invoicing of patients between hospitals, clinical research receipts and debt recoveries.
3The item « Other expenditure » mainly covers financial charges, maintenance contracts, minor equipment purchases, insurance contracts and other administrative costs.